诺辉健康 New Horizon Health Limited

Cayman Islands · 12 Employees
New Horizon Health Limited (Incorporated in the Cayman Islands with limited liability) Company Overview Founded in 2015, New Horizon Health is the pioneer and leader in China's cancer screening market, with a vision to prevent and cure cancer by screening and early detection. Company has two commercialized medical tests for colorectal cancer screening, and two late-stage pipeline candidates for gastric and cervical cancer screening respectively. Company holds global rights to all its marketed and pipeline products. A home-based, non-invasive, national-guideline-recommended FIT-DNA test targeting 120 million colorectal high-risk population in China, ColoClear is the first and only cancer screening test approved by NMPA. Pupu Tube, NMPA approved and CE Mark obtained, is the first self-conducted FIT screening test targeting 630 million population to identify colorectal high-risk individuals in China. In addition, Company has a synergistic screening pipeline portfolio focusing on high-incidence cancer types in China. Goldman Sachs (Asia) L.L.C. and UBS Securities Hong Kong Limited are the Joint Sponsors. Company Strengths -Pioneer and the only player with NMPA-approved products in China's cancer screening market, which has a high entry barrier protected by technical, clinical, and regulatory hurdles. -ColoClear as the first and only colorectal cancer screening test validated by large-scale prospective registrational trial in China, offering tremendous clinical utility and social value -Focused and synergistic cancer screening portfolio, including late-stage pipelines focusing on high-incidence cancer types in China -Multi-pronged commercialization approach to maximize the potential of ColoClear and Pupu Tube. -Visionary and experienced management team supported by strong healthcare investors. Company Strategies -Further develop the cancer screening market in China. -Increase market penetration of ColoClear and Pupu Tube in China.

概述

国家 Cayman Islands
成立时间 2015
总部 醫療, KY
电话号码 +10571-86430935
网站 http://www.newhorizonbio.com
LinkedIn http://www.linkedin.com/company/%e8%ab%be%e8%bc%9d%e5%81%a5%e5%ba%b7
Twitter
Facebook
员工数 12
行业 research,
简介 诺辉健康是中国癌症早筛的引领者和居家检测的开创者,中国首家专注于癌症早筛的生物高科技公司,率先提出“高发癌症居家早期筛查”的服务理念。其自主研发的“非侵入性,多靶点粪便FIT-DNA联合检测”产品--常卫清®是中国首个,且现阶段唯一的肠癌早筛产品。产品管线覆盖肠癌、宫颈癌、胃癌和肺癌等领域。针对中国人高发癌种,诺辉健康致力于提供最适宜的早期筛查解决方案,让用户足不出户即可享受准确高效、便捷的癌症早筛服务。

技术

Baidu Ads

Advertising Networks

Google Font API

Fonts

Microsoft Office 365

Other

Mobile Friendly

Other

Nginx

Load Balancers

Remote

Other

常见问题

诺辉健康 New Horizon Health Limited 在哪里?

诺辉健康 New Horizon Health Limited 的总部位于 醫療, KY

诺辉健康 New Horizon Health Limited 的电话号码是多少?

诺辉健康 New Horizon Health Limited 的电话号码是 +10571-86430935

诺辉健康 New Horizon Health Limited 的官方网站是什么?

诺辉健康 New Horizon Health Limited 的公司官方网站是 http://www.newhorizonbio.com

诺辉健康 New Horizon Health Limited 是做什么的?

诺辉健康是中国癌症早筛的引领者和居家检测的开创者,中国首家专注于癌症早筛的生物高科技公司,率先提出“高发癌症居家早期筛查”的服务理念。其自主研发的“非侵入性,多靶点粪便FIT-DNA联合检测”产品--常卫清®是中国首个,且现阶段唯一的肠癌早筛产品。产品管线覆盖肠癌、宫颈癌、胃癌和肺癌等领域。针对中国人高发癌种,诺辉健康致力于提供最适宜的早期筛查解决方案,让用户足不出户即可享受准确高效、便捷的癌症早筛服务。

诺辉健康 New Horizon Health Limited 的业务有哪些?

pcr,ivd

诺辉健康 New Horizon Health Limited 的年收入是多少?

诺辉健康 New Horizon Health Limited 的收入是 33381000美元

诺辉健康 New Horizon Health Limited 有多少员工?

诺辉健康 New Horizon Health Limited 有 12 名员工

诺辉健康 New Horizon Health Limited 属于哪个行业?

诺辉健康 New Horizon Health Limited 从事以下行业: research

诺辉健康 New Horizon Health Limited 使用什么技术?

诺辉健康 New Horizon Health Limited 使用的一些流行技术包括: Baidu Ads,Google Font API,Microsoft Office 365,Mobile Friendly,Nginx,Remote

如何联系 诺辉健康 New Horizon Health Limited?

诺辉健康 New Horizon Health Limited 联系信息: 电话号码:+10571-86430935, 网站:http://www.newhorizonbio.com, 邮箱:ema***@***.com

诺辉健康 New Horizon Health Limited 的社交媒体链接是什么?

诺辉健康 New Horizon Health Limited 领英:http://www.linkedin.com/company/%e8%ab%be%e8%bc%9d%e5%81%a5%e5%ba%b7,fackbook:,twitte:

诺辉健康 New Horizon Health Limited 是一家上市公司吗?

是的,诺辉健康 New Horizon Health Limited是一家上市公司,在sehk公开挂牌上市,上市交易代码:06606

诺辉健康 New Horizon Health Limited 的最后一轮融资是什么时候?

暂无最近投资信息

谁投资 诺辉健康 New Horizon Health Limited?

诺辉健康 New Horizon Health Limited 有 0 家投资者,包括 。

管理层

Amy Zhou

Senior Director of PR & Marketing

Hei Chan

Senior Scientist

员工

Yu Gao

Chief Financial Officer

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google